New: NCI-funded clinical trial search
Mednet Logo

When considering cytoreductive nephrectomy in metastatic kidney cancer, in which situations would you consider nephron-sparing approaches such as partial nephrectomy or SBRT?

How do you balance the therapeutic efficacy of CN with long-term CKD risk from radical nephrectomy?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Lewisburg Cancer Center | Evangelical Hospital
Answered on · Updated on

Nephron-sparing strategies (partial nephrectomy or stereotactic radiation therapy are reserved for patients with limited disease, favorable anatomy, or contraindications to surgery, where the goal is to maximize oncologic control while preserving renal function and minimizing morbidity. Careful multidisciplinary evaluation is essential to identify appropriate candidates.

Partial nephrectomy is appropriate for patients with unilateral, surgically resectable tumors (especially T1–T2) where nephron preservation is possible and oncologic control is not compromised, or when nephron preservation is imperative such as solitary kidney, bilateral tumors, or pre-existing renal insufficiency, or young age or comorbidities that increase the risk of prog...

Join for free or sign in to see the full answer